<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00523562</url>
  </required_header>
  <id_info>
    <org_study_id>protocol 140/04/CE/FBM</org_study_id>
    <nct_id>NCT00523562</nct_id>
  </id_info>
  <brief_title>Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity</brief_title>
  <acronym>MACRONUTR</acronym>
  <official_title>Study of the Role of Insulin Resistance in the Pathogenesis of the Metabolic Syndrome and of Non-alcoholic Steatohepatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess how the macronutrient composition of the diet effects

        -  lipid and glucose metabolism

        -  intrahepatic lipids

        -  insulin sensitivity

      in healthy lean subjects and in subjects with a high metabolic risk (ie overweight and
      offsprings of patients with type 2 diabetes mellitus).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is aimed at assessing the effects of changes in total energy, sugars, lipids, and
      protein intake on intrahepatic lipids, plasma lipids, and hepatic and whole body insulin
      resistance in

        -  lean men and women with no family history of diabetes

        -  overweight men and women

        -  lean men with a family history of type 2 diabetes

      Subjects are studied after a 6-day period of

        -  isocaloric diet with 100% calorie requirement, of which 55% carbohydrate, 15% protein,
           and 30% fat)

        -  the same isocaloric diet supplemented with 3g/kg body weight/day fructose

        -  hypercaloric high fat diet with 130% energy requirement, of which 55% carbohydrate, 15%
           protein, 60% fat

        -  hypercaloric high fat+protein diet with 145% energy requirement, of which 55%
           carbohydrate, 30% protein, 60% fat

      Measurements performed after 6 days on each diet include

        -  intrahepatic and intramyocellular lipids (1H-MRS)

        -  hepatic and whole body insulin sensitivity (hyperinsulinemic-euglycemic clamp)

        -  body weight

        -  plasma concentrations of hormones and substrates

        -  gene expression profile in skeletal muscle (vastus lateralis) and adipose tissue
           (subcutaneous abdominal)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasma triglycerides</measure>
    <time_frame>6 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>intra-hepatic lipids</measure>
    <time_frame>6 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin mediated glucose disposal</measure>
    <time_frame>6 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>lipid oxidation</measure>
    <time_frame>6 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma beta-hydroxybutyrate</measure>
    <time_frame>6 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gene expression in skeletal muscle and adipose tissue</measure>
    <time_frame>6 days</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Metabolic Syndrome X</condition>
  <condition>Liver Diseases</condition>
  <arm_group>
    <arm_group_label>normal weight male high fructose diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal weight subjects on a 6 day- high fructose diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>offsprings of T2DM high fructose diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy non-obese offsprings of patients with type 2 diabetes on a 6-day high fructose diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal weight subjects high fat diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>healthy male subjects on a 4-day high fat diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal weight high fat+protein diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects on a 4-day high fat+protein diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diet intervention</intervention_name>
    <description>controled hypercalori high fructose, high fat, or high fat/high protein diet</description>
    <arm_group_label>normal weight male high fructose diet</arm_group_label>
    <arm_group_label>offsprings of T2DM high fructose diet</arm_group_label>
    <arm_group_label>normal weight subjects high fat diet</arm_group_label>
    <arm_group_label>Normal weight high fat+protein diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females

          -  Age 18-40

          -  Informed consent obtained

          -  Subgroup with overweight (body mass index [BMI] &gt; 25)

          -  Subgroup with family history of type 2 diabetes mellitus

        Exclusion Criteria:

          -  Smokers

          -  Alcohol intake &gt; 30g/day

          -  Drug abuse

          -  Diabetes mellitus

          -  Any concurrent medication

          -  Having a pacemaker

          -  History of orthopedic surgery

          -  History of metal foreign bodies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luc Tappy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Lausanne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <zip>CH-1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2007</study_first_submitted>
  <study_first_submitted_qc>August 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2007</study_first_posted>
  <last_update_submitted>October 27, 2010</last_update_submitted>
  <last_update_submitted_qc>October 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof. L uc Tappy</name_title>
    <organization>Department of Physiology, University of Lausanne</organization>
  </responsible_party>
  <keyword>fructose</keyword>
  <keyword>dietary lipids</keyword>
  <keyword>dietary proteins</keyword>
  <keyword>hepatic steatosis</keyword>
  <keyword>insulin resistance</keyword>
  <keyword>Healthy humans</keyword>
  <keyword>overweight humans</keyword>
  <keyword>obese humans</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

